Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-06-28 Sale | 2024-07-01 6:00 pm | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 3,452 | $12 | $41,438 | 280,476 (Indirect Direct) | View |
| 2024-05-01 Sale | 2024-05-02 6:19 pm | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 20,000 | $14.13 | $282,577 | 283,928 (Indirect Direct) | View |
| 2024-04-01 Sale | 2024-04-03 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 20,000 | $16.15 | $323,000 | 303,928 (Indirect Direct) | View |
| 2024-03-15 Sale | 2024-03-19 4:47 pm | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 20,000 | $17.26 | $345,200 | 323,928 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-14 Option Award | 2024-08-16 9:13 pm | N/A 2034-08-14 | GYRE THERAPEUTICS INC. | GYRE | Nussbaum Rodney L Director | 52,000 | $0 | 52,000 (Direct) | View |
| 2024-08-14 Option Award | 2024-08-16 9:10 pm | N/A 2034-08-14 | GYRE THERAPEUTICS INC. | GYRE | Parry Renate Director | 52,000 | $0 | 52,000 (Direct) | View |
| 2024-08-14 Option Award | 2024-08-16 9:07 pm | N/A 2034-08-14 | GYRE THERAPEUTICS INC. | GYRE | Epstein David M. Director | 52,000 | $0 | 52,000 (Direct) | View |
| 2024-08-14 Option Award | 2024-08-16 9:05 pm | N/A 2034-08-14 | GYRE THERAPEUTICS INC. | GYRE | Carmichael Gordon Director | 52,000 | $0 | 52,000 (Direct) | View |
| 2024-08-14 Option Award | 2024-08-16 9:01 pm | N/A 2034-08-14 | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 26,000 | $0 | 26,000 (Direct) | View |
| 2024-08-14 Option Award | 2024-08-16 8:58 pm | N/A 2034-08-14 | GYRE THERAPEUTICS INC. | GYRE | Eastling Thomas Wilson Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2024-08-14 Option Award | 2024-08-16 8:56 pm | N/A 2034-08-14 | GYRE THERAPEUTICS INC. | GYRE | Luo Ying Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2024-08-14 Option Award | 2024-08-16 8:53 pm | N/A 2034-08-14 | GYRE THERAPEUTICS INC. | GYRE | Chen Ruoyu Chief Financial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2024-08-14 Option Award | 2024-08-16 8:50 pm | N/A 2034-08-14 | GYRE THERAPEUTICS INC. | GYRE | Ying Han Chief Executive Officer | 341,000 | $0 | 341,000 (Direct) | View |
| 2024-08-06 Option Award | 2024-08-08 4:31 pm | N/A 2034-08-06 | GYRE THERAPEUTICS INC. | GYRE | Epstein David M. Director | 1,866 | $0 | 1,866 (Direct) | View |
| 2024-06-28 Exercise | 2024-07-01 6:00 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 3,452 | $6.93 | 280,476 (Direct) | View |
| 2024-06-28 Exercise | 2024-07-01 6:00 pm | N/A 2033-10-31 | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 3,452 | $0 | 280,476 (Direct) | View |
| 2024-05-01 Exercise | 2024-05-02 6:19 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 20,000 | $6.93 | 283,928 (Direct) | View |
| 2024-05-01 Exercise | 2024-05-02 6:19 pm | N/A 2033-10-31 | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 20,000 | $0 | 283,928 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 4:01 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 20,000 | $6.93 | 303,928 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 4:01 pm | N/A 2033-10-31 | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 20,000 | $0 | 303,928 (Direct) | View |
| 2024-03-20 Option Award | 2024-03-21 8:31 pm | N/A 2034-03-20 | GYRE THERAPEUTICS INC. | GYRE | Nussbaum Rodney L Director | 1,866 | $0 | 1,866 (Direct) | View |
| 2024-03-15 Exercise | 2024-03-19 4:47 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 20,000 | $6.93 | 323,928 (Direct) | View |
| 2024-03-15 Exercise | 2024-03-19 4:47 pm | N/A 2033-10-31 | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 20,000 | $0 | 323,928 (Direct) | View |
| 2023-11-20 Option Award | 2023-11-22 7:55 pm | N/A 2030-10-31 | GYRE THERAPEUTICS INC. | GYRE | Luo Ying Director | 5,613,652 | $0 | 11,294,404 (Direct) | View |
| 2023-10-30 Other | 2023-11-22 7:55 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | Luo Ying Director | 2,840,376 | $0 | 11,294,404 (Indirect) | View |
| 2023-11-20 Option Award | 2023-11-22 7:49 pm | N/A 2030-10-31 | GYRE THERAPEUTICS INC. | GYRE | Ye Weiguo Chief Operating Officer | 1,665,115 | $0 | 1,665,115 (Direct) | View |
| 2023-11-20 Option Award | 2023-11-22 7:40 pm | N/A 2030-10-31 | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,510,047 | $0 | 4,510,047 (Direct) | View |
| 2023-11-20 Option Award | 2023-11-22 7:34 pm | N/A 2030-10-31 | GYRE THERAPEUTICS INC. | GYRE | Chen Ruoyu Chief Financial Officer | 578,540 | $0 | 578,540 (Direct) | View |
| 2023-10-30 Other | 2023-11-22 7:27 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | GNI Group Ltd. GNI USA Inc. 10% Owner | 63,588,119 | $0 | 127,594,006 (Indirect) | View |
| 2023-11-20 Option Award | 2023-11-22 7:20 pm | N/A 2030-10-31 | GYRE THERAPEUTICS INC. | GYRE | Wu Charles C Chief Executive Officer | 170,417 | $0 | 170,417 (Direct) | View |
Ownership(A) | 2023-11-22 7:06 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 0 | $0 | 2,942,467 (Indirect) | View |
| 2023-10-31 Option Award | 2023-11-01 06:15 am | N/A 2033-10-31 | GYRE THERAPEUTICS INC. | GYRE | Luo Ying Director | 1,866 | $0 | 1,866 (Direct) | View |
| 2023-10-31 Option Award | 2023-11-01 06:15 am | N/A 2033-10-31 | GYRE THERAPEUTICS INC. | GYRE | Eastling Thomas Wilson Director | 316,518 | $0 | 316,518 (Direct) | View |
| 2023-10-31 Option Award | 2023-11-01 06:15 am | N/A 2033-10-31 | GYRE THERAPEUTICS INC. | GYRE | Parry Renate Director | 1,866 | $0 | 1,866 (Direct) | View |
| 2023-10-31 Option Award | 2023-11-01 06:15 am | N/A 2033-10-31 | GYRE THERAPEUTICS INC. | GYRE | Chen Ruoyu Interim CFO | 34,380 | $0 | 34,380 (Direct) | View |
| 2023-10-31 Option Award | 2023-11-01 06:15 am | N/A 2033-10-31 | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 343,518 | $0 | 343,518 (Direct) | View |
| 2023-10-31 Option Award | 2023-11-01 06:15 am | N/A 2033-10-31 | GYRE THERAPEUTICS INC. | GYRE | Ying Han Director | 1,866 | $0 | 1,866 (Direct) | View |
| 2023-10-31 Option Award | 2023-11-01 06:15 am | N/A 2033-10-31 | GYRE THERAPEUTICS INC. | GYRE | Carmichael Gordon Director | 1,866 | $0 | 1,866 (Direct) | View |
Ownership | 2023-10-27 8:01 pm | N/A N/A | CATALYST BIOSCIENCES INC. | CBIO | GNI Group Ltd. GNI USA Inc. 10% Owner | 0 | $0 | 129,666,521 (Indirect) | View |